139 related articles for article (PubMed ID: 32220019)
1. Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment.
Hasegawa M; Shimizu A; Ieta K; Shibusawa K; Ishikawa O; Ishida-Yamamoto A; Tamura A
J Dermatol; 2020 Jun; 47(6):e241-e242. PubMed ID: 32220019
[No Abstract] [Full Text] [Related]
2. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
Gupta D; Chandrashekar L; Larizza L; Colombo EA; Fontana L; Gervasini C; Thappa DM; Rajappa M; Rajendiran KS; Sreenath GS; Kate V
Int J Dermatol; 2017 Feb; 56(2):195-201. PubMed ID: 28074523
[TBL] [Abstract][Full Text] [Related]
3. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).
Vale Rodrigues R; Santos F; Pereira da Silva J; Francisco I; Claro I; Albuquerque C; Lemos MM; Limbert M; Dias Pereira A
Fam Cancer; 2017 Apr; 16(2):267-270. PubMed ID: 27771813
[TBL] [Abstract][Full Text] [Related]
4. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
5. [Familial gastrointestinal stroma tumor due to mutation in exon 13 (K642E) of the KIT gene].
Peña-Irún A; Villa-Puente M; García-Espinosa R; Cavadas-López A
Med Clin (Barc); 2012 Nov; 139(11):512-3. PubMed ID: 22626674
[No Abstract] [Full Text] [Related]
6. [Not Available].
Hompland I; Hølmebakk T; Boye K; Stoldt S; Bjerkehagen B; Berner JM; Wiedswang AM; Revheim ME; Poulsen JP; Hall KS; Bruland ØS
Tidsskr Nor Laegeforen; 2018 Oct; 138(15):. PubMed ID: 30277049
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Gastrointest Endosc; 2016 Dec; 84(6):950-958.e3. PubMed ID: 27118626
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors.
Miettinen M; Lasota J
Gastroenterol Clin North Am; 2013 Jun; 42(2):399-415. PubMed ID: 23639648
[TBL] [Abstract][Full Text] [Related]
9. Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.
Hedenström P; Nilsson B; Demir A; Andersson C; Enlund F; Nilsson O; Sadik R
World J Gastroenterol; 2017 Aug; 23(32):5925-5935. PubMed ID: 28932084
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
ESMO / European Sarcoma Network Working Group
Ann Oncol; 2012 Oct; 23 Suppl 7():vii49-55. PubMed ID: 22997454
[No Abstract] [Full Text] [Related]
11. Gastrointestinal Stromal Tumor.
Guo R; Erickson LA
Mayo Clin Proc; 2019 Feb; 94(2):373-374. PubMed ID: 30711139
[No Abstract] [Full Text] [Related]
12. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
Marano L; Boccardi V; Marrelli D; Roviello F
Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
[TBL] [Abstract][Full Text] [Related]
13. Gastric Gastrointestinal Stromal Tumors (GIST): a Case Series and Current State of the Art in the Workup and Treatment of This Rare Disease.
Sharma NR; Gopakumar H; Harrison S; Ehmke N; Zelt C
J Gastrointest Cancer; 2019 Sep; 50(3):548-555. PubMed ID: 29192406
[No Abstract] [Full Text] [Related]
14. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
[TBL] [Abstract][Full Text] [Related]
15. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy.
Martínez-Marín V; Maki RG
Gastroenterol Clin North Am; 2016 Sep; 45(3):477-86. PubMed ID: 27546844
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
Reichardt P; Reichardt A
Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
[TBL] [Abstract][Full Text] [Related]
17. Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor.
Wada N; Kurokawa Y; Takahashi T; Hamakawa T; Hirota S; Naka T; Miyazaki Y; Makino T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Oncology; 2016; 90(2):112-7. PubMed ID: 26779618
[TBL] [Abstract][Full Text] [Related]
18. Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis.
Speight RA; Nicolle A; Needham SJ; Verrill MW; Bryon J; Panter S
J Clin Oncol; 2013 Jun; 31(16):e245-7. PubMed ID: 23610110
[No Abstract] [Full Text] [Related]
19. Disappearance of lentigines in a patient receiving imatinib treatment for familial gastrointestinal stromal tumor syndrome.
Campbell T; Felsten L; Moore J
Arch Dermatol; 2009 Nov; 145(11):1313-6. PubMed ID: 19917964
[TBL] [Abstract][Full Text] [Related]
20. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
